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A B S T R A C T  
 
The clinical presentation of patients with acute glomerulonephritis (GN) varies widely, from 
asymptomatic to clinical presentations of acute kidney injury (AKI), edema, and hypertension. 
Diagnosis of GN in patients with diabetic nephropathy (DN) is a challenge due to pre-existing 
edema, hypertension, and decreased renal function. Likewise in terms of management of 
steroid immunosuppressants related to blood sugar regulation. It has been reported that 35-
year-old male patients with diabetes mellitus (DM) with DN whose kidney function 
deteriorated rapidly. The patient complained of cola-red urine and decreased urine volume 
the day before admission. Physical examination showed blood pressure of 160/95 mmHg, 
bilateral leg edema, active chronic ulcer in the left lower leg, hemoglobin level was 8.7 g / dl, 
leukocytes 17.400 / ul, serum urea level 96 mg / dl, serum creatinine level 7.01 mg / dl, ASTO 
titer + 800 IU / ml, macroscopic hematuria, and albuminuria +4 on urinalysis. Ultrasonography 
revealed enlarged kidney size and signs of acute renal inflammation. Based on these data the 
patient was diagnosed clinically as rapidly progressive GN due to post-infectious GN. The 
patient received 3 days of pulse methyl prednisolone therapy continued orally, blood sugar 
regulation with insulin, RAS blockers, intravenous antibiotics and ulcer debridement. After 1 
week of therapy, clinical and laboratory improvements were found and at the next follow-up 
renal function returned to baseline about 2 weeks later. 
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I N T R O D U C T I O N  
 The kidney is an organ that is often the 
target of a pathogenic immune response, both 
to local autoantigens and by local 
manifestations of a systemic autoimmunity. 
Based on clinical, immunological and 
experimental data, it supports the hypothesis 
that the majority of glomerulonephritis (GN) in 
humans is the result of immunological 
mechanisms. The pathogenetic mechanisms of 
GN are numerous and complex, involving both 
humoral and cell-mediated immune responses. 
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 The nature of the immune response 
that causes GN is strongly influenced by its 
immunogenic phenotype.[1] The most common 
mechanism of GN is the deposition of immune 
deposits (antigen-antibody complexes), on the 
glomerular basement membrane (GBM), the 
sub-endothelium and on the sub-epithelium 
which is often associated with clinical 
manifestations. Immune complex deposition is 
followed by an inflammatory response with 
activation of the complement factor cascade 
and infiltration of hematopoietic cells (such as 
neutrophils and macrophages), as well as 
glomerular cell proliferation. Furthermore, 
these effector cells induce thrombosis, necrosis 
and crescent formation which can lead to renal 
insufficiency and rapidly progressive 
nephritis.[2] 
 The most common causes of nephritic 
syndrome are post infectious GN, IgA 
nephropathy and lupus nephritis. Acute PSGN is 
an immune complex-mediated GN associated 
with streptococcal infection of the skin or 
throat. In contrast to pediatric patients, the 
source of infection in adults is more 
heterogeneous, which can come from 
infections of the skin, upper respiratory tract, 
lungs, oral mucosa, and urinary tract. Currently, 
the incidence rate has decreased, especially in 
developed countries. Most cases affect adults, 
especially those who are elderly or people with 
impaired immune systems. [3,4] Clinical features 
vary widely from asymptomatic microscopic 
hematuria to severe acute nephritic 
syndrome.[3] The diagnosis of PSGN is generally 
based on clinical and laboratory information. 
whereas a kidney biopsy is generally rarely 
required. Treatment of PSGN focuses on 
managing hypertension and edema. Antibiotic 
penicillin to eradicate the nephritogenic strain 
of streptococci when the infection is active, 
whereas steroid therapy is generally only given 
to patients with progressive renal failure or the 
presence of crescents on the renal biopsy.[5] 
PSGN has an excellent prognosis especially in 
children with complete recovery usually 
occurring within 6 to 8 weeks. In adults, around 
50% of the patients continue to have reduced 
renal function, hypertension, or persistent 
proteinuria. [6,7] The following reports a case 
with problems in diagnosis and management in 
a patient with underlying DN who experienced 
rapid decline in renal function and hematuria. 
C A S E  R E P O R T 
 A 35-year-old man came to the 
emergency room with complaints that his urine 
was red like cola (Figure 1) and his urine 
production had decreased since 1 day before 
going to the hospital. He is a DM patient for 12 
years and is regularly taking oral anti-diabetes 
drugs. The patient was known to have 
hypertension since 2 years ago and was 
receiving 300 mg of irbesartan and 10 mg of 
amlodipine. The patient complained of swelling 
of both legs and ulcers on the left lower leg 
since 3 months ago. Physical examination 
revealed obesity, blood pressure 160/95 mmHg, 
pulse 105 beats / minute, respiratory rate 18 
times / minute, temperature 36.7 C. There was 
bilateral leg edema, open necrotic, peeling, and 
wound on the lower left leg (Figure 2). Since the 
onset of edema, patient mobilization has 
become more limited.  
 Laboratory tests showed leukocytosis 
(17.400 / µL), hemoglobin level 8.7 g / dl, serum 
urea level was 96 mg / dl, serum creatinine level 
was 7.01 mg / dl, level of HbA1c was 9.7% and 
ASTO titer was + (800) IU / ml. The urine was 
cola red and on urinalysis protein 4+. 
Ultrasonography revealed a relatively enlarged 
kidney size and signs of inflammation 
consistent with the acute condition (Figure 3). 
Based on clinical and laboratory data the 
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patient was diagnosed as acute post-
streptococcal glomerulonephritis, diabetic 
nephropathy, type II diabetes mellitus, and 
chronic ulcer in cruris. The patient received 
intravenous antibiotic therapy, Irbesartan 300 
mg, amlodipine 10 mg, pulse steroid using 
methylprednisolone 750 mg for 3 days and 
continued orally and planned for hemodialysis. 
During methyl prednisolone therapy, the blood 
sugar level was 380 mg / dL, so that the oral 
antidiabetic was replaced by insulin. After 1 
week of therapy, there was clinical and 
laboratory improvement and at the next follow-
up renal function returned to baseline about 2 
weeks later. 
 
Figure 1. Clinical picture of the patient’s urine that looks 
like cola. 
Figure 2. Clinical picture of the patient’s skin ulcer that 
appears to be still active. 
Figure 3. Renal sonography showing enlarged kidneys 
with normal cortex density and clear cortical medullary 
boundaries. The length of the right kidney was 14.23 cm 
and the left was 13.18 cm.  
DISCUSSION 
 Diagnosis of rapidly deteriorating renal 
function in patients with DN background is a 
challenge. Many factors or conditions can be 
the cause, including DM-related conditions and 
the metabolic syndrome itself as well as DN 
conditions, as a secondary nephrotic 
syndrome. This patient was obese, had 
prominent bilateral edema, impaired mobility, 
hypoalbumin, poor blood sugar control (HbA1C 
9.7%) and had chronic ulcers in the lower limbs 
which appeared to be still active. Based on the 
patient's clinical condition, several possible 
diagnoses can be made, including acute GN, 
papillary necrosis, or renal vein thrombosis.  
 Patients with nephrotic syndrome, low 
levels of albumin in the blood, a high level of 
cholesterol in the blood and swelling, triggering 
a hypercoagulable state and increasing 
chances of clot formation. Almost two-thirds of 
patients have bilateral renal vein involvement. 
Thrombosis may extend from the vena cava 
into the peripheral venules or may originate in 
the peripheral veins and propagate to the main 
renal vein. The severe passive congestion that 
develops causes the kidney to swell and 
become engorged, leading to degeneration of 
nephrons and causing symptoms of flank pain, 
hematuria and decreased urine output.[8] 
 Renal papillary necrosis involves a severe 
destructive process, possibly as a result of 
ischemia of the medulla and papilla. The papilla 
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is very sensitive to these ischemic changes 
because even in normal settings it is exposed to 
a relatively hypoxic environment. Clinically, 
papillary necrosis often manifests as low back 
pain, hematuria, and fever. Urinalysis shows 
red and white blood cells, bacteria, and 
papillary fragments. These papillary fragments 
can cause ureteral obstruction which requires 
immediate intervention.[9]  
 The differential diagnosis of GN is very 
broad and complex. Based on the clinical 
presentation the above patient is presenting 
with a nephritic syndrome with rapid 
progression (rapidly progressive GN). GN that is 
rapidly progressive can occur in the conditions 
of PSGN, IgAN, HSP, LN and MPGN.[10] Based on 
existing data with additional ASTO examination 
with high titers, the patient above was 
diagnosed as RPGN due to PSGN with the 
existing source of infection being cellulitis in 
the lower left leg, poor control type 2 diabetes 
mellitus and DN.  
 Raised on anti-streptolysin O (ASO) titer 
is only found in 80% of patients who did not 
receive antibiotics during the phase of 
streptococcal infection. ASO titers increase 
when there is infection by Group A beta 
hemolytic streptococci, Group C or Group G 
streptococci. The antibody response to 
streptococcal extracellular products is a useful 
marker of recent infection. If the test result is 
positive, it confirms a recent invasive 
streptococcal infection. The antibody response 
usually detected during the 2nd or 3rd weeks of 
an acute episode and peaks at 4th to 5th weeks. 
ASO titer tend to increase in 1st week after 
infection, peak at weeks 3 to 5, and begin to 
decrease after 8 weeks; and a stronger response 
is due to pharyngeal infections vs skin 
infections. However, a high ASO titer is not 
definitively diagnose poststreptococcal 
complications.[11] 
 Management recommended for patients 
with acute post-streptococcal nephritic 
syndrome is symptomatic based on the severity 
of the disease. The main goals are controlling 
hypertension and edema. During the acute 
phase, the patient's diet was 35 cal / kg / day, 
the protein diet reduced from 0.5 to 0.7 grams / 
kg / day, unsaturated fat, and low salt, namely 
2 grams of sodium per day. Electrolyte intake 
must also be limited, sodium 20 mEq per day, 
potassium less than 70–90 mEq per day and 
calcium 600–1000 mg per day. Strict fluid 
restriction by limiting the intake of 1 liter of 
fluids per day, to treat hypertension. The 
therapy for hypertension is diuretics, if remains 
unresolved, the 2nd line is calcium channel 
blockers, ACE inhibitors or intravenous 
nitroprusside for malignant hypertension. In 
severe cases with hyperkalemia and severe 
uremic syndrome is indicated for 
hemodialysis.[5] 
 Intravenous steroid is indicated for the 
glomerulonephritis with a lesion more than 
30% of the total glomerulus. 
Methylprednisolone 500 mg intravenously per 
day in 4 divided doses for 3–5 days. 
Methylprednisolone pulse is globally tolerable 
in diabetic patients.[12] However, some 
references stated that the usage was not 
indicated for long-term. Serial insulin and 
continuous glucose measurements should be 
performed to elucidate the side effect of 
steroid. The patient was given 
Methylprednisolone 500 mg intravenously per 
day for 3 days. Patient had a clinically 
significant improvement as well as kidney 
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function after the treatment. During the 
administration of pulse steroids, the patient's 
blood sugar increases. The patient was treated 
initially with oral diabetes drug, then changed 
to basal bolus insulin when the patient is 
started on pulse steroids. In theory, it should be 
considered to change the dosage of basal 
insulin and increase short/fast acting insulin by 




C O N C L U S I O N 
 A case has been reported in a 35-year-
old male patient with a nephritic syndrome 
with clinical manifestation of rapidly 
progressive GN due to streptococcal infection. 
Diagnosis and management are constrained by 
the condition of patients with underlying 
diabetic nephropathy and poor glucose 
control. The patient received pulse steroid 
therapy, blood glucose control with insulin, 
systemic antibiotics and debridement of the 
ulcer. Renal function improved to baseline 
values around 14 days of therapy. 
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